Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Gland Pharma Ltd.
Swot
Gland Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Gland Pharma Ltd. has 17 Strengths, 10 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(17)
Weakness
(10)
Opportunity
(2)
Threats
(2)
Others
(6)
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Revenue and Profit
Annual net profit declining for last 2 years
Fall in Quarterly Revenue and Net Profit (YoY)
Top Losers
Companies with Upcoming Results
FII / FPI or Institutions increasing their shareholding
MFs decreased their shareholding last quarter
Insiders sold stocks
Bullish or Bearish Candlestick Strength - Indices
Upside Tasuki Gap (Bullish Continuation)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
